FIELD: chemistry; biochemistry.
SUBSTANCE: invention relates to bioengineering and specifically to obtaining biologically active substances of peptide nature, which have growth factor activity towards fibroblast proliferation and can be used in medicine. An oligopeptide of formula A-X1-X2-X3-X4-X5-B is obtained through in silico construction, where A is F; X1 is E, or Q, or S; X2 is N, or Q, or A, or G; X3 is K, or R, or T; X4 is K, or E, or is absent, X5 is K, or L, or is absent and B is OMe - methyl.
EFFECT: invention enables obtaining an oligopeptide with transformation growth factor (TGF-β) and oncostatin M (OSM) towards fibroblast proliferation, and expansion of the range of effective therapeutic agents with wound-healing effect, which take part in closing wounds during inflammation and cicatrisation.
4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OLIGOPEPTIDE HAVING ACIDIC (aFGF) AND TRANSFORMING (TGF-β) GROWTH FACTOR ACTIVITY TOWARDS STIMULATION OF COLLAGEN BIOSYNTHESIS | 2008 |
|
RU2385873C2 |
| OLIGOPEPTIDE WITH ACTIVITY OF VASCULAR ENDOTHELIUM GROWTH FACTOR (VEGF) WITH RESPECT TO ANGIOGENESIS STIMULATION | 2008 |
|
RU2375373C1 |
| PEPTIDE SHOWING GROWTH STIMULATING ACTIVITY OF HEPATOCYTE GROWTH FACTOR (HGF) | 2009 |
|
RU2426740C1 |
| OLIGOPEPTIDE WITH STEM CELL FACTOR CSF ACTIVITY TOWARDS THYMOCYTE DIFFERENTIATION | 2008 |
|
RU2374262C1 |
| OLIGOPEPTIDE HAVING CARTILAGE-DERIVED MORPHOGENETIC PROTEIN (CDMP-1) ACTIVITY ON CHONDROCYTE PROLIFERATION | 2009 |
|
RU2408603C1 |
| OLIGOPEPTIDE HAVING NEUREGULIN-1 ACTIVITY ON CARDIOMYOCYTE PROLIFERATION | 2010 |
|
RU2439078C1 |
| PEPTIDE HAVING GROWTH-STIMULATING FACTOR OF HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR | 2008 |
|
RU2385875C2 |
| THYROID GLAND FOLLICULAR CELL PROLIFERATION STIMULATING OLIGOPEPTIDE | 2008 |
|
RU2393166C1 |
| METHOD FOR PREDICTING THE DURATION OF A RELAPSE-FREE PERIOD IN PATIENTS WITH RESECTABLE THRICE-NEGATIVE BREAST CANCER | 2021 |
|
RU2780922C1 |
| METHOD FOR DETERMINING THERAPEUTIC APPROACH IN PATIENTS WITH METASTATIC FORMS AND RECURRENT TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2818730C1 |
